Search research articles
Contact Us
Filters
Showing results (321-330 of 427) with videos related to
Page
of 43
Sort By:
British Journal of Haematology
|
March 19, 2016
Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trial
Elias K Mai, Axel Benner, Uta Bertsch, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 3, 2026
Interpreting [<sup>18</sup>F]FDG-avid fractures after induction therapy in multiple myeloma: insights from the PET/CT sub-study of the Phase 3 GMMG-HD7 trial
Christos Sachpekidis, Marina Hajiyianni, Markus Wennmann, et al.
Haematologica
|
May 13, 2017
Longitudinal fluorescence <i>in situ</i> hybridization reveals cytogenetic evolution in myeloma relapsing after autologous transplantation
Maximilian Merz, Anna Jauch, Thomas Hielscher, et al.
The New England Journal of Medicine
|
November 8, 2018
Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma
Meletios A Dimopoulos, Dominik Dytfeld, Sebastian Grosicki, et al.
Blood
|
February 8, 2007
Protein kinase C inhibitor enzastaurin induces in vitro and in vivo antitumor activity in Waldenstrom macroglobulinemia
Anne-Sophie Moreau, Xiaoying Jia, Hai T Ngo, et al.
Leukemia
|
October 11, 2023
High-throughput electron tomography identifies centriole over-elongation as an early event in plasma cell disorders
Sebastian Köhrer, Tobias Dittrich, Martin Schorb, et al.
Haematologica
|
June 7, 2021
Chromosome 1q21 abnormalities refine outcome prediction in patients with multiple myeloma - a meta-analysis of 2,596 trial patients
Niels Weinhold, Hans J Salwender, David A Cairns, et al.
Haematologica
|
June 29, 2023
Clonal hematopoiesis with <i>DNMT3A</i> and <i>PPM1D</i> mutations impairs regeneration in autologous stem cell transplant recipients
Patrick Stelmach, Sarah Richter, Sandra Sauer, et al.
Haematologica
|
January 20, 2022
Comprehensive genomic analysis of refractory multiple myeloma reveals a complex mutational landscape associated with drug resistance and novel therapeutic vulnerabilities
Nicola Giesen, Nagarajan Paramasivam, Umut H Toprak, et al.
Frontiers in Immunology
|
November 30, 2023
RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma
Martina Emde-Rajaratnam, Susanne Beck, Vladimir Benes, et al.
Page
of 43
Search research articles
Search
Showing results (321-330 of 427) with videos related to
Sort By:
Page
of 43
British Journal of Haematology
|
March 19, 2016
Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trial
Elias K Mai, Axel Benner, Uta Bertsch, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 3, 2026
Interpreting [<sup>18</sup>F]FDG-avid fractures after induction therapy in multiple myeloma: insights from the PET/CT sub-study of the Phase 3 GMMG-HD7 trial
Christos Sachpekidis, Marina Hajiyianni, Markus Wennmann, et al.
Haematologica
|
May 13, 2017
Longitudinal fluorescence <i>in situ</i> hybridization reveals cytogenetic evolution in myeloma relapsing after autologous transplantation
Maximilian Merz, Anna Jauch, Thomas Hielscher, et al.
The New England Journal of Medicine
|
November 8, 2018
Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma
Meletios A Dimopoulos, Dominik Dytfeld, Sebastian Grosicki, et al.
Blood
|
February 8, 2007
Protein kinase C inhibitor enzastaurin induces in vitro and in vivo antitumor activity in Waldenstrom macroglobulinemia
Anne-Sophie Moreau, Xiaoying Jia, Hai T Ngo, et al.
Leukemia
|
October 11, 2023
High-throughput electron tomography identifies centriole over-elongation as an early event in plasma cell disorders
Sebastian Köhrer, Tobias Dittrich, Martin Schorb, et al.
Haematologica
|
June 7, 2021
Chromosome 1q21 abnormalities refine outcome prediction in patients with multiple myeloma - a meta-analysis of 2,596 trial patients
Niels Weinhold, Hans J Salwender, David A Cairns, et al.
Haematologica
|
June 29, 2023
Clonal hematopoiesis with <i>DNMT3A</i> and <i>PPM1D</i> mutations impairs regeneration in autologous stem cell transplant recipients
Patrick Stelmach, Sarah Richter, Sandra Sauer, et al.
Haematologica
|
January 20, 2022
Comprehensive genomic analysis of refractory multiple myeloma reveals a complex mutational landscape associated with drug resistance and novel therapeutic vulnerabilities
Nicola Giesen, Nagarajan Paramasivam, Umut H Toprak, et al.
Frontiers in Immunology
|
November 30, 2023
RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma
Martina Emde-Rajaratnam, Susanne Beck, Vladimir Benes, et al.
Page
of 43